Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maher

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|September 10, 2013
Antitumor immunity: easy as 1, 2, 3 with monoclonal bispecific trifunctional antibodies?John Maher, Antonella A Adami
Clinical and Translational Medicine|May 11, 2022
3D modelling of γδ T-cell immunotherapyCaroline M Hull, John Maher
Immunotherapy|March 26, 2015
ErbB-targeted CAR T-cell immunotherapy of cancerLynsey M Whilding, John Maher
Blood|August 1, 2015
TSLPR: a new CAR in the showroom for B-ALLDavid Marc Davies, John Maher
Cancer Cell|January 8, 2021
Crosstown Traffic: Lymphodepleting Chemotherapy Drives CAR T CellsDavid M Davies, John Maher
Expert Opinion on Biological Therapy|May 1, 2019
Novel approaches to promote CAR T-cell function in solid tumorsCaroline M Hull, John Maher
Immunotherapy|August 4, 2017
'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumorsDavid E Gilham, John Maher
Cancers|February 25, 2023
CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging TargetsJohn Maher, David M Davies
Archivum Immunologiae Et Therapiae Experimentalis|April 8, 2010
Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cellsDavid Marc Davies, John Maher
Best Practice & Research. Clinical Haematology|June 19, 2018
Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safetyLeena Halim, Adam Ajina, John Maher
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|September 10, 2013
Antitumor immunity: easy as 1, 2, 3 with monoclonal bispecific trifunctional antibodies?John Maher, Antonella A Adami
Clinical and Translational Medicine|May 11, 2022
3D modelling of γδ T-cell immunotherapyCaroline M Hull, John Maher
Immunotherapy|March 26, 2015
ErbB-targeted CAR T-cell immunotherapy of cancerLynsey M Whilding, John Maher
Blood|August 1, 2015
TSLPR: a new CAR in the showroom for B-ALLDavid Marc Davies, John Maher
Cancer Cell|January 8, 2021
Crosstown Traffic: Lymphodepleting Chemotherapy Drives CAR T CellsDavid M Davies, John Maher
Expert Opinion on Biological Therapy|May 1, 2019
Novel approaches to promote CAR T-cell function in solid tumorsCaroline M Hull, John Maher
Immunotherapy|August 4, 2017
'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumorsDavid E Gilham, John Maher
Cancers|February 25, 2023
CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging TargetsJohn Maher, David M Davies
Archivum Immunologiae Et Therapiae Experimentalis|April 8, 2010
Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cellsDavid Marc Davies, John Maher
Best Practice & Research. Clinical Haematology|June 19, 2018
Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safetyLeena Halim, Adam Ajina, John Maher
Pageof 14